Know more

About cookies

What is a "cookie"?

A "cookie" is a piece of information, usually small and identified by a name, which may be sent to your browser by a website you are visiting. Your web browser will store it for a period of time, and send it back to the web server each time you log on again.

Different types of cookies are placed on the sites:

  • Cookies strictly necessary for the proper functioning of the site
  • Cookies deposited by third party sites to improve the interactivity of the site, to collect statistics

Learn more about cookies and how they work

The different types of cookies used on this site

Cookies strictly necessary for the site to function

These cookies allow the main services of the site to function optimally. You can technically block them using your browser settings but your experience on the site may be degraded.

Furthermore, you have the possibility of opposing the use of audience measurement tracers strictly necessary for the functioning and current administration of the website in the cookie management window accessible via the link located in the footer of the site.

Technical cookies

Name of the cookie


Shelf life

CAS and PHP session cookies

Login credentials, session security



Saving your cookie consent choices

12 months

Audience measurement cookies (AT Internet)

Name of the cookie


Shelf life


Trace the visitor's route in order to establish visit statistics.

13 months


Store the anonymous ID of the visitor who starts the first time he visits the site

13 months


Identify the numbers (unique identifiers of a site) seen by the visitor and store the visitor's identifiers.

13 months

About the AT Internet audience measurement tool :

AT Internet's audience measurement tool Analytics is deployed on this site in order to obtain information on visitors' navigation and to improve its use.

The French data protection authority (CNIL) has granted an exemption to AT Internet's Web Analytics cookie. This tool is thus exempt from the collection of the Internet user's consent with regard to the deposit of analytics cookies. However, you can refuse the deposit of these cookies via the cookie management panel.

Good to know:

  • The data collected are not cross-checked with other processing operations
  • The deposited cookie is only used to produce anonymous statistics
  • The cookie does not allow the user's navigation on other sites to be tracked.

Third party cookies to improve the interactivity of the site

This site relies on certain services provided by third parties which allow :

  • to offer interactive content;
  • improve usability and facilitate the sharing of content on social networks;
  • view videos and animated presentations directly on our website;
  • protect form entries from robots;
  • monitor the performance of the site.

These third parties will collect and use your browsing data for their own purposes.

How to accept or reject cookies

When you start browsing an eZpublish site, the appearance of the "cookies" banner allows you to accept or refuse all the cookies we use. This banner will be displayed as long as you have not made a choice, even if you are browsing on another page of the site.

You can change your choices at any time by clicking on the "Cookie Management" link.

You can manage these cookies in your browser. Here are the procedures to follow: Firefox; Chrome; Explorer; Safari; Opera

For more information about the cookies we use, you can contact INRAE's Data Protection Officer by email at or by post at :


24, chemin de Borde Rouge -Auzeville - CS52627 31326 Castanet Tolosan cedex - France

Last update: May 2021

Menu Logo Principal Oniris

Home page

Epidemiological modelling and its use to manage COVID-19

Insights into mechanistic models, by the DYNAMO team

Over the next few weeks, we will present some key elements of epidemiological modelling through short educational articles. These articles will help you to better understand and decipher the assumptions underlying the epidemiological models that are currently widely used, and how these assumptions can impact predictions regarding the spread of pathogens, particularly SARS-CoV-2. The objective is to discover the advantages and limitations of mechanistic modelling, an approach that is at the core of the DYNAMO team's work. The examples of models will be inspired by models used in crisis, but sometimes simplified to make them accessible.

#11 - Analysis of the sensitivity of the COVID19 model to parameter variations

In this post, we analyze the sensitivity of the model presented in article #6, with the values of parameters estimated in article #8. We simultaneously varied by 10% all the model parameters (table) except the previously estimated date of virus introduction (22/01), as well as the start (16/3) and end (11/5) dates of containment fixed as observed. We used here a FAST (Fourier Amplitude Sensitivity Test) sampling protocol, and the "sensitivity" package under the R software.

Table of model parameters



Values (min-max)


Basal transmission rate (d-1)

1.48 (1.332-1.628)


Factor reducing the excretion of Ip, Ia, Ips (%)

0.47 (0.423-0.517)


Residual contacts of Iss (%)

0.25 (0.225-0.275)


Residual contacts of H & ICU (%)

0.25 (0.225-0. 275)


Latency exit rate (d-1)

0.30 (0.270-0.330)


Exit rate from state Ip (j-1)

0.66 (0.600-0.733)


[pa, pps, pms, pss]

Variation factor

Probability of being Ia, Ips, Ims or Iss (sum = 1)

1.00 (0.900-1.100)

[f*[0.3,0.2,0.3], 1-f*0.8]


Exit rate from states Ia, Ips, Ims, Iss (j-1)

0.43 (0.391-0.478)


Probability to enter an intensive care unit after Iss

0.25 (0.225-0. 275)


Hospital exit rate (d-1)

0.07 (0.060-0.073)


Proportion of H that will eventually recover (%)

0.90 (0.89-0.91)


Intensive care exit rate (d-1)

0.05 (0.045-0.055)


Proportion of ICU that will eventually recover (%)

0.70 (0.67-0.73)


Residual contact during lockdown

0.10 (0.09-0.11)


Residual contact after lockdown (distancing)

0.50 (0.450-0.550)

For illustration purposes, we focus on three outputs of the model: the number of cases at the date of the epidemic peak (PeakValue), the date of the peak (PeakDate), and the cumulative number of deaths over the simulated period (CumDeaths). The Figure below shows that the number of cases at the peak and the cumulative number of deaths over the period are outputs governed by the same Parameters, essentially the basal transmission rate (b) and residual ISS (s) contacts. Thus, the contribution of ISS prevails in the dynamics of infection. Next comes the duration of the latency phase (1/ε). The date of the peak is influenced by ε, as well as the duration in the infectious (1/γ), the duration in the intensive care unit (1/γICU) and residual contact during containment (c1). Parameters explaining less than 10% of the variation in an output are generally considered non-influential.

Indices de sensibilité (FAST) pour les trois sorties analysées

It is therefore clear that not all outputs of the same model are necessarily influenced by the same parameters, and that the relevant outputs should be analysed before interpreting the predictions of a model. Furthermore, the results also indicate that the date of the epidemic peak is not very sensitive to interactions between parameters. On the contrary, the two other outputs are strongly influenced by interactions between the parameters involved in the transmission capacity of ISS individuals, which should be better specified to improve the accuracy of the model. Finally, some parameters do not seem to impact these three outputs. If the range of variation tested is indeed relevant (10% could be a little low for some parameters) and if only these outputs are of interest, then there is no need to work towards better estimating these parameters, or the model can even be simplified.

Noteworthy, the data used in article #8 are not sufficient to estimate the values of the model's key parameters accurately enough, with confidence intervals of more than 10% around the likely values. More data are therefore required before going any further in an accurate way!